Researchers at Massachusetts General Hospital (MGH) have found a noninvasive brain imaging procedure to be an objective and reliable way to identify individuals whose performance has been impaired by THC, the psychoactive ingredient in cannabis. The technique uses imaging technology known as functional near-infrared spectroscopy (fNIRS) to measure brain activation patterns that correlate to impairment from THC intoxication. As reported in the journal Neuropsychopharmacology, the procedure could have significant implications for improving highway and workplace safety.
The need for mental health care in children and adolescents has been surging; rates of suicide and self-harm are increasing, and, like hospitals, primary care [...]
Even slight exposure to light can prompt the critical sleep-promoting hormone melatonin to plummet in preschoolers in the hour before bedtime, potentially disrupting slumber long [...]
CHAMPS (Communities and Hospitals Advancing Maternity Practices), a multi-year quality improvement (QI) initiative in the state of Mississippi led by Boston Medical Center (BMC) researchers, [...]